1. Home
  2. DLO vs CORT Comparison

DLO vs CORT Comparison

Compare DLO & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DLocal Limited

DLO

DLocal Limited

HOLD

Current Price

$11.24

Market Cap

3.2B

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$72.62

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLO
CORT
Founded
2013
1998
Country
Uruguay
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.7B
IPO Year
2021
2001

Fundamental Metrics

Financial Performance
Metric
DLO
CORT
Price
$11.24
$72.62
Analyst Decision
Strong Buy
Buy
Analyst Count
8
5
Target Price
$17.25
$96.50
AVG Volume (30 Days)
2.9M
1.0M
Earning Date
05-14-2026
04-30-2026
Dividend Yield
1.45%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$761,407,000.00
Revenue This Year
$41.00
$26.08
Revenue Next Year
$26.98
$26.98
P/E Ratio
$22.27
N/A
Revenue Growth
N/A
12.79
52 Week Low
$9.75
$28.66
52 Week High
$16.78
$91.00

Technical Indicators

Market Signals
Indicator
DLO
CORT
Relative Strength Index (RSI) 38.43 80.07
Support Level $10.90 $68.20
Resistance Level $13.66 $79.89
Average True Range (ATR) 0.53 2.57
MACD -0.03 0.87
Stochastic Oscillator 34.15 87.98

Price Performance

Historical Comparison
DLO
CORT

About DLO DLocal Limited

DLocal Ltd is focused on making the complex simple, redefining the online payment experience in emerging markets. Through its technology platform, One dLocal, the company enables world-wide enterprise merchants to get paid (pay-in) and to make payments (pay-out) online in a safe and efficient manner. The company earns revenue from fees charged to merchants in connection with payment processing services for cross-border and local payment transactions. The company operates in a single operating segment, which is payment processing. The company's geographical segments include Latin America and Non-Latin America, with a majority of its revenue being generated from Brazil in the Latin America region.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: